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Vitiligo is a skin disease characterized by absence of 
melanin due to melanocytes destruction. Aim: to study the 
incidence of hearing alterations in patients with vitiligo. 
Method: prospective audiological evaluation, transient-
evoked otoacoustic emission recordings and study the 
effects of suppression in 24 patients with vitiligo. Their ages 
ranged from 15 to 45 years. Results: 21 patients (87.5%) had 
normal audiometry; 2 had unilateral hearing loss in the high 
frequencies and 1 had cochlear moderate hearing loss in 
the left ear. Of these 21 subjects, 66.7% had no otoacoustic 
emissions, suggesting cochlear dysfunction. Only 7 patients 
had otoacoustic emissions present in all frequencies (29.2%) 
and 17 (70.8%) did not have them, and the highest rate 
of no otoacoustic emissions happened in the right ear of 
males. Regarding the suppression study, 6 subjects failed, 
all of them were females, and their left ears were the most 
affected. Conclusion: the findings show that patients with 
vitiligo, particularly males, have a greater predisposition to 
cochlear dysfunction, especially in the right ear. As far as 
the suppression effect was concerned, there was a greater 
alteration in the female efferent system, particularly in the left 
ear. Hearing alterations did not vary as far as age is concerned, 
type of vitiligo and time of disease progression.
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INTRODUCTION
Vitiligo is an idiopathic acquired skin disease cha-
racterized by pearl-white patches of diverse shapes and 
sizes, caused by a loss of melanocytes (cells that synthesize 
melanin). It affects 1% of the general population, of which 
about 30% have a family history. It affects every race, and 
has no sex prevalence. The initial manifestations usually 
start at an age between 20 and 30 years, although the onset 
may occur in early infancy.1,2
The etiology is unknown, but some theories have 
been used to explain the disease: 
1) auto-immunity - due to frequent associations with 
other auto-immune disease such as thyroiditis and type I 
diabetes, the presence of anti-melanocyte antibodies, and 
a response to immunosuppressant therapy; 
2) cytotoxicity - the possibility that metabolites for-
med during melanin synthesis may destroy melanocytes; 
3) neural - chemical mediators released at nerve 
endings might destroy melanocytes or inhibit melanin 
production; 
4) free radicals - excess free radicals might be toxic 
for melanocytes; 
5) convergent - a combination of these theories.2
Vitiligo may be classified as localized, segmental, 
generalized and universal, according to the area of pig-
mentation loss.2
Alphonse Corti (1831) was the first researcher to 
mention the presence of pigment cells in the inner ear.3 
There are many melanocytes in the human cochlea, par-
ticularly in the modiolus, in the osseous spiral lamina, 
in Reissner’s membrane and in the vascular stria; mela-
nocytes are found especially in highly vascularized areas 
of apparently important secretory or metabolic function.3-5 
Although its exact role - and that of melanin - remains 
unknown, it is probable that they have a vasomotor 
function in the inner ear.3,4 According to Savin (1965)3 
cells containing pigments are partially or fully adhered to 
blood vessel walls, which are sites of intense metabolite 
exchanges. For this author, melanin facilitates the passage 
of substances from one side to the other, thus maintaining 
cell membrane equilibrium. Furthermore, melanin may 
have an important role in the inner ear, since hearing is 
affected in systemic disorders that affect pigmented areas 
(eyes, skin and hair) such as the Vogt-Koyanagi and Wa-
ardenburg syndromes.3
The inner ear contains many melanocytes, particu-
larly in the basal area of the cochlea, which is responsible 
for high sound frequencies, those that are affected earlier 
by ototoxic drugs and intense noise exposure.4,6,7 Conlee 
et al. (1995) studied the effect of gentamicin in animals 
and concluded that melanin could inhibit the toxicity of 
these drugs by binding to them; melanin would thus have 
a protective role for the cochlea.8
Carvalho (2004) found that otoacoustic emissions 
and the high frequency sensitivity auditory function was 
affected negatively in patients with pigment disorders, 
such as vitiligo.9
Recent studies have suggested a direct relation 
between cochlear dysfunction and decreased amounts of 
melanin. It is thus thought that melanin has a protective 
role against harmful agents in the inner ear.4,5,7 Loss of me-
lanocytes, resulting in decreased melanin production - as 
occurs in Vitiligo - could decrease cochlear health.
The clinical uses of research on otoacoustic emis-
sions and the suppression effect of contralateral noise 
have grown in importance. These are early detection me-
thods of changes in cochlear function, even before these 
changes manifest themselves in hearing; they are also fast 
and non-invasive methods. Additionally, Guedes et al. 
(2002)10 found that in normal individuals the amplitude 
of transient evoked otoacoustic emissions (TOAE) vary 
little in intra-subject tests and retest, which strengthens its 
use in monitoring the hearing before symptoms manifest 
themselves.
The purpose of this study was to verify whether 
fewer melanocytes altered cochlear function, by measuring 
and analyzing TOAE, and to verify the function of the me-
dial olivocochlear efferent system, by studying the effect 
of TOAE suppression in subjects with pigment disorders 
such as vitiligo.
METHOD
The Research Ethics Committee approved this study 
(number 1065/06), which was undertaken at the outpatient 
unit of the Disciplina de Distúrbios de Audição (Hearing 
Disorders Discipline), Departamento de Fonoaudiologia 
(Speech Therapy Department), Universidade Federal de 
Sao Paulo (Sao Paulo Federal University).
All participants signed a free informed consent 
form. The sample in this study consisted of 24 subjects 
with vitiligo referred to the dermatology department of a 
university hospital. There were 15 female subjects (8 with 
generalized type vitiligo and 7 with localized type vitiligo) 
and 9 male subjects (5 with generalized type vitiligo and 
4 with localized type vitiligo). The age ranged from 15 to 
45 years (mean age - 31.29 years), and the mean duration 
of the disease was 9.23 years. The inclusion criteria were 
as follows: no history of otological diseases, no tinnitus, 
no having been subjected to intense noise, no past use of 
ototoxic drugs, and no family history of hearing loss. All 
patients were being treated dermatologically.
The clinical history was taken from each participant 
to establish the inclusion criteria; the external acoustic 
meatus was inspected to check for conditions that might 
interfere with the tests and the full audiological assess-
ment. Testing comprised pure tone audiometry (MAICO 
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41 audiometer with TDH 39 earphones and an MX 41 
pad - ANSI-69 standard) at 250 Hz, 500 Hz, 1 KHz, 2 KHz, 
3 KHz, 4 KHz, 6 KHz, and 8 KHz in an acoustically trea-
ted test suite; normalcy was based on the criteria of the 
American Speech-language-hearing Association (ASHA, 
1978)11 for thresholds below or equal to 20 dBHL, and 
conventional logoaudiometry (the speech recognition 
score - SRS, and the speech reception threshold - SRT). 
Normal result criteria adopted in this study were 92 to 
100% of right answer in the SRS and intensities from 0 to 
5dBHL over SRT thresholds.
Acoustic immittance tests consisted of tympanome-
try and investigation of the contralateral stapedian reflex 
(Interacoustics model AT - 235 middle ear analyzer); 
normal criteria were an A-type curve and contralateral 
stapedian muscle reflexes present and with intensities of 
70 to 90 dBHL over the threshold.
Finally, patients underwent otoacoustic emissions 
testing (Otodynamics, London, ILO 96 Cochlear Emissions 
Analyzer) with a non-linear click at 80 microsecond re-
gular pulses (duration of stimulus), a 50 cycle-per-second 
repetition frequency, and an 80 dBpeSPL (sound pressure 
equivalent peak) with 3 dBSPL, at a 6 000 Hz bandwidth 
and a 20 millisecond window. A series of 260 stimuli in 
blocks of four clicks in each test were presented. Con-
tralateral acoustic stimulation was done with continuous 
white noise transmitted at an intensity of 50 dBSPL by a 
TDH 39 earphone to check for the absence or presence 
of otoacoustic emissions suppression.
The following order of tests was used in this study: 
TOAE in the right ear with no noise; TOAE in the right 
ear with contralateral noise; TOAE in the left ear with no 
noise; TOAE in the left ear with contralateral noise.
The normalcy criterion was the presence of TOAE 
3 dB over noise in each frequency range (1 KHz, 1.5 KHz, 
2 KHz, 3 KHz, and 4 KHz) with reproducibility equal to 
or over 70% and probe stability equal to or higher than 
70%.
The suppression value of the olivocochlear system is 
given by the difference between values gathered with and 
with no contralateral stimulation for each ear; this value 
defines whether there is suppression of the amplitude of 
emissions or not.12-14 A suppression effect was considered 
as present when the TOAE amplitudes decreased by at least 
0.5 dBSPL in the presence of contralateral noise. According 
to Collet et al. (1992), a 0.5 to 1.0 dB suppression effect 
reveals that the medial olivocochlear system is intact.15 
It was considered as absent if the was no such decrease 
(zero or negative difference).13,14
The significance value (p) was 5% (0.050) for the 
statistical tests and data analysis. The Fisher’s statistics 
adjusted chi-square test was applied to verify possible 
differences among categories in each case.
RESULTS
Twenty-one (87.5%) of 24 patients with vitiligo (13 
of the generalized type and 11 of the localized type) had 
normal pure tone audiometries, two had unilateral hearing 
loss (one in the right ear and one in the left ear) between 
3 000 Hz and 8 000 Hz, and one had moderate cochlear 
loss in the left ear; thus, 12.5% of patients had hearing loss. 
Fourteen (66.7%) of 21 patients with normal audiometries 
presented partial (at 4 KHz) or absent TOAE, suggesting 
cochlear dysfunction. There were no sex-related statisti-
cally significant differences in conventional audiometry. 
Emissions were present at all frequencies in only seven 
patients (29.2%), and absent in 17 patients (70.8%), as 
shown in Table 1.
Table 1. Occurrence of hearing loss and transient otoacoustic emis-
sions according to sex.
Normal 
audiometry  
Hearing 
loss
TOAE 
presente
TOAE
absent
Male 8 (88,9%) 1 (11,1%) 1 (11,1%) 8 (88,8%)
Female 13 (86,7%) 2 (13,3%) 6 (40%) 9 (60%)
21 (87,5%) 3 (12,5%) 7 ( 29,2%) 17 (70,8%)
Eleven (64.7%) of 17 patients in which TOAE were 
absent had bilateral failure, and six (35.2%) had unilateral 
failure. Four (36.3%) of 11 subjects with bilateral failure 
presented these failures at all frequency bands, and seven 
subjects (63.6%) had failure only at high frequencies (3 
KHz and 4 KHz). Two female patients of six subjects with 
unilateral failure presented failure at all frequency bands 
in the left ear, and four patients had failure only at 4 000 
Hz, of which three failed in the left ear.
There were no statistically significant differences in 
conventional audiometry as related to the type of vitiligo 
(p=0.566).
Altered emissions were more frequent in males 
compared to females (77.8% in which TOAE were absent), 
a difference that was statistically significant only in the 
right ear (p=0.035).
There were no statistically significant differences 
in the occurrence of TOAE in relation to the type of viti-
ligo (p=0.648), the duration of disease (p=0.406), or age 
(p=0.510), as shown in Tables 2 and 3.
Suppression was investigated in 18 cases with 
bilateral emissions of the 24 sample subjects. There was 
bilateral suppression in 12 cases (66.6%), and absence of 
suppression in six cases (33.3%); all of these patients were 
female, with a statistically significant difference compared 
to males (p=0.034).
The two cases with unilateral TOAE (right ear only) 
were also taken into account in the assessment of the sup-
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pression effect per ear. The findings revealed that the left 
ear was more harmed; this difference in the occurrence of 
suppression relative to the side was statistically significant 
(p=0.024). Occurrence in the left ear (66.7%) was lower 
compared to the right ear (95%). The type of vitiligo did 
not affect the occurrence of suppression.
DISCUSSION
We found in this study that there was a 12.5% hea-
ring loss percentage in conventional pure tone audiometry. 
In studies on this theme, the evaluation of hearing revealed 
similar results (decreased hearing).
Tosti et al. (1987)16 found hearing loss in 16% of 
subjects with vitiligo; they raised the hypothesis that part 
of the melanocytes was injured by auto-immunity due to 
vitiligo. Auto-immunity is one of the accepted etiological 
theories of vitiligo.
Sharma et al. (2004)17 found that 18.9% of vitiligo pa-
tients had hearing loss at 2 000 Hz to 4 000 Hz, all of which 
were bilateral in a sample comprising 180 subjects.
Aydogan et al. (2005)18 assessed the audiological 
thresholds between 250 and 8 000 Hz and the electro-
physiological potentials in 57 subjects with vitiligo and 50 
healthy subjects. These authors found that 14% of vitiligo 
patients presented mild sensorineural dysacusis, of whi-
ch six had bilateral hearing loss and two had unilateral 
hearing loss. They concluded that their findings, together 
with other published data, suggested that melanin might 
have an important role in establishing and/or maintaining 
the structure and function of the auditory system and in 
modulating the transduction of auditory stimuli in the 
inner ear.
Carvalho M. (2004)9 found seven patients (23.3%), in 
a sample of 30 vitiligo subjects, with thresholds above 25 
dB in conventional audiometry. However, when compared 
with the control group, the authors found statistically sig-
nificant differences only in high frequency audiometry.
Ardic et al. (1998)7 studied 29 subjects with vitiligo 
compared with a 41-subject control group, applying au-
diometry from 250 Hz to 16 KHz. This author found pure 
tone thresholds between 4 000 Hz and 10 000 Hz in the 
vitiligo group, which was significantly worse compared 
with the control group. Male patients presented hearing 
loss at higher frequency ranges than female patients, which 
was statistically significant. They concluded that vitiligo is 
a significant hearing loss factor, and that males are more 
vulnerable than females.
Our findings in the present study (hearing loss in 
12.5% of subjects) are similar to other published results.7,9,16-
18 Our study thus strengthens the hypothesis that vitiligo is 
a significant factor for altered cochlear function, and that 
melanin may in fact have an important role in cell meta-
bolism, facilitating substance exchanges and maintaining 
endolymph, perilymph and ionic balance.19
Our findings also show that TOAE are a sensitive 
test for detecting cochlear dysfunction before symptoms 
become manifest, as TOAE were absent in 66.7% of 
subjects with normal audiometries. Carvalho M. (2004) 
concluded that emissions (distortion product, or DPOAE) 
and high frequency audiometry are sensitive tests for 
identifying cochlear dysfunction in vitiligo subjects.9 Our 
findings support this statement, adding that conventional 
audiometry with TOAE testing are reliable tests for the 
early detection of cochlear dysfunction.
Additionally in our study, we found increased au-
ditory vulnerability in male subjects, as demonstrated by 
absent TOAE; this finding is similar to Ardic et al.’s results 
(1998).7 TOAE suppression studies have shown a more 
significant absence of suppression in females, showing 
altered auditory efferent pathways, specifically in the 
medial olivocochlear tract.
We found no published papers on the use of TOAE 
and the suppression effect in vitiligo.
There were no statistically significant differences in 
the present study related to the duration of vitiligo, or to 
age. Other published papers have also found no statisti-
cally significant differences related to the duration of the 
disease or age, compared to controls.18
Patients with suspected retrocochlear dysfunction 
due to lack of suppression were referred to an Otorhino-
laryngologist and for brainstem audiometry.
We believe that all vitiligo patients required routine 
monitoring and audiological assessments by specialists 
for early identification and monitoring of changes as the 
disease progresses.
CONCLUSION
Vitiligo patients appear to be more predisposed to 
Table 2. Occurrence of otoacoustic emissions in relation to the dura-
tion of disease.
Present Absent
1 a 4 years 2 ( 18,2%) 9 (81,8%) 11
4 a 10 years 1 (16,7%) 5 (83,3%) 6
> 10 years 3 (42,9%) 4 (57,1%) 7
6 (25%) 18 (75%) 24
Table 3. Occurrence of otoacoustic emissions in relation to the age 
of patients.
Present Absent
15 a 30 years 2 (22,2%) 7 (77,7%) 9
30 a 43 years 5 (33,3%) 10 (66,7%) 15
7 ( 29,2%) 17 (70,8%) 24
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cochlear dysfunction, as shown by the absence of otoa-
coustic emissions, although pure tone audiometry was 
within normal limits in most of the sample; this group 
was also more likely to develop changes in the medial 
olivocochlear efferent system.
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